At Nashik Diagnopein Centre, the JAK-2 (RT-PCR) test is performed using advanced molecular technology, ensuring precise detection for conditions such as Polycythemia Vera
Report Availability
24 hours
The JAK-2 (RT-PCR) test, also known as the JAK2 V617F mutation test, is a highly accurate molecular diagnostic technique used to identify genetic mutations associated with myeloproliferative neoplasms (MPNs). The test detects the JAK2 V617F gene mutation using Real-Time Polymerase Chain Reaction (RT-PCR), which offers exceptional sensitivity, specificity, and reliability.
The JAK-2 RT-PCR mutation test is highly valuable in clinical diagnosis because it helps confirm the presence of a genetic alteration responsible for uncontrolled blood cell growth. Detecting this mutation early supports timely decision-making and treatment planning.
Importance of JAK-2 RT-PCR Testing
Accurate detection of myeloproliferative disorders
Conditions like Polycythemia Vera (PV), Essential Thrombocythemia (ET), and Myelofibrosis (MF) are strongly associated with the JAK2 mutation.
Helps differentiate primary vs secondary blood abnormalities
Many patients develop high hemoglobin or elevated platelets due to lifestyle or environmental factors. The JAK-2 test clarifies whether these are genetic or non-genetic.
Supports targeted treatment
Confirming the presence of the mutation helps doctors create a personalized treatment plan.
Monitors treatment progress
The test can be used in follow-up to understand how the disease is responding to therapy.
High sensitivity
RT-PCR ensures accurate detection even when the mutation is present in low quantity.
Reduces need for invasive investigations
A conclusive molecular test avoids unnecessary procedures.
At Nashik Diagnopein Centre, the JAK2 RT-PCR test is performed under strict quality protocols to deliver reliable results every time.
Patients and doctors trust Nashik Diagnopein Centre because of our advanced molecular testing setup and experienced pathology team. The JAK-2 RT-PCR test provides several clinical and diagnostic benefits:
Highly accurate molecular detection using latest RT-PCR equipment.
Fast reporting with proper interpretation.
Improved clinical outcomes through early diagnosis and timely intervention.
Supports hematologists and oncologists in making treatment decisions.
Minimally invasive testing requiring only a blood sample.
Precision in identifying mutation burden, helping doctors understand disease severity.
International-standard testing environment for maximum accuracy.
Enhanced patient safety, proper sample handling, and strict QC checks.
Because of its high accuracy, the JAK2 V617F RT-PCR test has become a routine investigation in the evaluation of abnormal blood cell counts. Nashik Diagnopein Centre ensures trusted results that clinicians rely on for patient management.
The JAK-2 RT-PCR mutation test is conducted in a well-equipped molecular lab with controlled conditions.
Sample Collection
A blood sample (EDTA) is collected by trained phlebotomists at Nashik Diagnopein Centre.
DNA Extraction
Genetic DNA is separated from blood cells.
Amplification via RT-PCR
Using real-time PCR, the DNA is amplified to identify whether the JAK2 V617F mutation is present.
Mutation Detection
The system reads fluorescence signals to detect and quantify mutation.
Internal Quality Control
Every test includes positive and negative controls for accuracy.
Expert Interpretation
Molecular specialists at Nashik Diagnopein Centre evaluate the final results.
This procedure ensures accurate, quick, and reliable detection.
The JAK-2 test includes several critical parameters:
JAK2 V617F Mutation Presence
Mutation Allele Burden (Quantitative or Qualitative)
Internal Amplification Controls
Positive/Negative Mutation Status
Quality Check Indicators
DNA Amplification Efficiency
These parameters help doctors assess disease severity and shape treatment plans effectively.
Nashik Diagnopein Centre is a trusted name in advanced diagnostic testing. Our molecular lab is equipped with modern RT-PCR platforms, ensuring accurate detection of the JAK2 gene mutation. We prioritize patient care, accuracy, and timely reporting.
Experienced molecular pathologists
State-of-the-art RT-PCR machines
Strict sample handling and QC protocol
Transparent reporting structure
Fast and reliable results
Affordable testing charges
Comfortable testing environment
With dedicated support and high-quality diagnostics, Nashik Diagnopein Centre ensures precision for every JAK-2 (RT-PCR) test conducted.
No special preparation is required for the JAK-2 (RT PCR) test. It is a simple blood test, so you can continue with your regular activities before and after the test.
The JAK-2 (RT PCR) test is a simple blood test. A small sample of blood is taken from the patient, and the sample is then analyzed in the laboratory using PCR (Polymerase Chain Reaction) technology to detect the presence of the JAK-2 mutation.
The JAK-2 mutation, especially the V617F variant, is strongly associated with several blood disorders. Detecting the presence of this mutation helps in diagnosing MPNs, distinguishing between different types of these conditions, and guiding appropriate treatment plans.
The JAK-2 test is a safe procedure with minimal risk. The only discomfort you may experience is from the blood draw, which might cause slight bruising or soreness at the site of the needle insertion. These side effects typically resolve quickly.
